Fluconazole pharmacokinetics in burn patients

被引:24
作者
Boucher, BA
King, SR
Wandschneider, HL
Hickerson, WL
Hanes, SD
Herring, VL
Canada, TW
Hess, MM
机构
[1] Univ Tennessee, Ctr Hlth Sci, Dept Clin Pharm, Memphis, TN 38163 USA
[2] Univ Tennessee, Dept Plast Surg, Memphis, TN 38163 USA
[3] Univ Wisconsin Hosp & Clin, Dept Pharm Serv, Madison, WI 53792 USA
[4] Parkland Hlth & Hosp Syst, Dept Pharm Serv, Dallas, TX 75235 USA
[5] Univ Pittsburgh, Dept Pharm Practice, Pittsburgh, PA 15213 USA
关键词
D O I
10.1128/AAC.42.4.930
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The pharmacokinetics of fluconazole in nine adult patients with severe (30 to 95% total body surface area) burns were studied. There was no significant difference in half-life (t(1/2)), clearance (CL), or volume of distribution (V) over time in five patients bn days 3 and 8 of the study (P > 0.05). Combined parameter estimates (means +/- standard deviations) for all nine patients for the two study periods were as follows: t(1/2), 24.4 +/- 5.8 h; CL, 0.36 +/- 0.09 ml/min/kg; and V, 0.72 +/- 0.12 liters/kg. These estimates of t(1/2) and CL in burn patients were approximately 13% shorter and 30% more rapid, respectively, than the most extreme estimates reported for other populations.
引用
收藏
页码:930 / 933
页数:4
相关论文
共 31 条
  • [1] PHARMACOKINETICS OF TICARCILLIN CLAVULANATE IN SEVERELY BURNED PATIENTS
    ADAM, D
    ZELLNER, PR
    KOEPPE, P
    WESCH, R
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 : 121 - 130
  • [2] PHARMACOKINETICS OF SYSTEMICALLY ADMINISTERED ANTIBIOTICS IN PATIENTS WITH THERMAL-INJURY
    BOUCHER, BA
    KUHL, DA
    HICKERSON, WL
    [J]. CLINICAL INFECTIOUS DISEASES, 1992, 14 (02) : 458 - 463
  • [3] IMIPENEM PHARMACOKINETICS IN PATIENTS WITH BURNS
    BOUCHER, BA
    HICKERSON, WL
    KUHL, DA
    BOMBASSARO, AM
    JARESKO, GS
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1990, 48 (02) : 130 - 137
  • [4] Clinical pharmacokinetics of piperacillin-tazobactam combination in patients with major burns and signs of infection
    Bourget, P
    LesneHulin, A
    LeReveille, R
    LeBever, H
    Carsin, H
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1996, 40 (01) : 139 - 145
  • [5] VANCOMYCIN ELIMINATION IN PATIENTS WITH BURN INJURY
    BRATER, DC
    BAWDON, RE
    ANDERSON, SA
    PURDUE, GF
    HUNT, JL
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 1986, 39 (06) : 631 - 634
  • [6] CHIN T, 1990, PHARMACOTHERAPY, V10, P305
  • [7] DARGENIO DZ, 1997, ADAPT 2 PHARMACKINET
  • [8] CLINICAL PHARMACOKINETICS OF FLUCONAZOLE
    DEBRUYNE, D
    RYCKELYNCK, JP
    [J]. CLINICAL PHARMACOKINETICS, 1993, 24 (01) : 10 - 27
  • [9] CANDIDA INFECTION IN MASSIVELY BURNED PATIENTS
    DESAI, MH
    HERNDON, DN
    ABSTON, S
    [J]. JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 1987, 27 (10) : 1186 - 1188
  • [10] BA SIMPLE AND RAPID METHOD FOR DETERMINATION OF FLUCONAZOLE IN HUMAN PLASMA SAMPLES BY HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY
    FLORESMURRIETA, FJ
    GRANADOSSOTO, V
    HONG, E
    [J]. JOURNAL OF LIQUID CHROMATOGRAPHY, 1994, 17 (17): : 3803 - 3811